Frontiers  Cancer, more than a “COVID-19 co-morbidity”

Frontiers Cancer, more than a “COVID-19 co-morbidity”

4.9
(233)
Write Review
More
$ 21.50
Add to Cart
In stock
Description

Frontiers in Oncology Cancer Epidemiology and Prevention

Frontiers Host cell stress response as a predictor of COVID-19

Comorbidities, multimorbidity and COVID-19

Frontiers Effect of Comorbid Diabetes on Clinical

Frontiers Immuno-Thrombotic Complications of COVID-19

Which Comorbidities Increase the Risk of a COVID-19 Breakthrough

Frontiers Cancer, more than a “COVID-19 co-morbidity”

Frontiers Cancer, more than a “COVID-19 co-morbidity”

FAST: a fast and scalable factor analysis for spatially aware

Frontiers Case report: Understanding the impact of persistent

Frontiers The COVID-19/Tuberculosis Syndemic and Potential

Frontiers The worldwide impact of COVID-19 on cancer care: A

Frontiers Evaluation of the effect of the COVID-19 pandemic on